Activities & Sponsored Events
Saturday, June 27
Presenters: Judith Haber, PhD, APRN, BC, FAAN; Erin Hartnett, DNP, APRN-BC; Jill B. Fernandez, RDH, MPH; Paulomi Niles, CNM, MSN, MPH; Jacquelyn Fried, RDH, MS;
Facilitators: Alice Horowitz, PhD, RDH; Kellie Bryant, DNP, WHNP-BC
Oral health is key to overall health and well-being of pregnant women and their babies. The exciting interprofessional role of midwives in promoting oral health during pregnancy and preventing early childhood caries in their newborns will be emphasized. During this interactive workshop, clinical competencies related to oral health assessment, oral health promotion interventions, and collaborative partnerships with interprofessional community colleagues and resources will be developed. Strategies for integrating oral health competencies in midwifery program curricula, including Smiles for Life, will be presented.
Nexplanon Training Program
During the Clinical Training Program for NEXPLANON you will receive hands-on training for insertion and removal procedures as well as implant localization techniques. Completion of this course will allow you to order the product from authorized distributor(s). This session is not accredited for continuing education credit. The training is open only to MD/DO, NP, PA, CNMs or CMs and Residents authorized to perform the procedures entailed in the insertion and removal of NEXPLANON in the jurisdiction where they practice. Attendees are expected to attend the entire training which is approximately 3 hours in duration. Certificates of attendance will not be issued to those who arrive late or leave early.
Midwives of Color Reception
Heart of Midwifery
Sunday, June 28
Midwifery Business Network Reception
Monday, June 29
Presenter: Linda Dominguez
Medicines360 is an innovative nonprofit global pharmaceutical company focused exclusively on women’s health. We were formed in 2009 to provide all women with the ability to choose and obtain quality medicines, regardless of their socioeconomic status, insurance, or geographic location. Come to this session to learn about Medicines360's recently FDA-approved hormonal IUD.
Presenter: Melissa Stosic, MS, CGC, Director of Medical Education, Natera
Presentation on the advantages of Natera's unique technology for Non-Invasive Prenatal Testing (NIPT) and utilization in clinical practice.
Presenter: Dan McNeff
Upon completion of the presentation, the attendees will understand: Correct structuring strategies to protect all assets (business and personal) from any lawsuit, from any direction; How through understanding your legal structuring you can lower your income tax and eliminate capital gains and estate taxes; and the proper usage (individually and in strategic combination) of trusts, partnerships, and LLC's among other entities. With the current economic difficulties, people are more likely to resort to acts of desperation to get by. Taxes are climbing increasingly higher, and the nation in general has accepted the idea that lawsuits are a legitimate way to get income, even if the lawsuit is filed under false pretenses. This course will teach attendees how to protect 100% of their personal and business assets while reducing their taxes with the same tools.
PRESERVE-1 (Prospective Randomized Evaluation of the Safety and Efficacy of Recombinant Antithrombin in Very Preterm Pre-Eclampsia) is a Phase 3 clinical study for ATryn® [antithrombin (Recombinant)] for the treatment of preeclampsia diagnosed in pregnant women between 23 and 30 weeks gestational age. The goal of the study is to assess if the addition of antithrombin to the current treatment standard can safely prolong pregnancy and improve newborn outcomes. Learn more about the PRESERVE-1 study and study locations.
Tuesday, June 30
Presenter: Jessica Hooks, MS, CGC
Non-invasive prenatal testing has rapidly become a preferred method of aneuploidy screening, given its high sensitivity and low false positive rate. The recent publication of the landmark NEXT study in the New England Journal of Medicine directly compares the performance of first trimester combined screening to the Harmony non-invasive prenatal test in a general pregnancy population of almost 16,000 women. Come join us for a detailed review of the results of this study and discussion of the implications for utilization of NIPT in midwifery practice moving forward.
Nausea and Vomiting of Pregnancy (NVP): A Different Treatment Option
Speaker: Loral Patchen, CNM
Duchesnay USA is a unique health care company devoted to safeguarding the health and well-being of expectant women and their unborn babies. In April 2013, we received FDA approval of Diclegis® (doxylamine succinate 10 mg, pyridoxine hydrochloride 10 mg), available in pharmacies nationwide. To learn more, visit www.Diclegis.com, www.DuchesnayUSA.com, or visit us at Booth #601.
Lobby Day – ACNM will organize so that members can visit
congressional offices and discuss issues of importance to midwifery
Midwifery Celebration Afterparty